CLINICAL & PIPELINE·Drug Approval
Teva Pharmaceuticals' Sildenafil Citrate 20mg ANDA: Approval, Discontinuation, and Supply Chain Implications
Teva Pharmaceuticals' ANDA for Sildenafil Citrate 20mg tablets received FDA approval on January 7, 2013, but the product has since been discontinued. This event highlights critical considerations for pharmaceutical procurement and supply chain resilience. Decision-makers must analyze market dynamics that lead to generic discontinuations, assess potential supply chain vulnerabilities, and ensure robust alternative sourcing strategies for essential molecules like Sildenafil Citrate.
90-Day Activity